Enter to open, tab to navigate, enter to select
Juno Therapeutics, Inc. and AbVitro Inc. merger
| January 08, 2016 • Private Acquisition Agreements • $124.91 million (approximate deal value based on price of Buyer's common stock on signing date; subject to purchase price adjustment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.